SMLR vs. CDRE, TNDM, INMD, LQDA, KMTS, BLFS, MDXG, ESTA, FNA, and RXST
Should you be buying Semler Scientific stock or one of its competitors? The main competitors of Semler Scientific include Cadre (CDRE), Tandem Diabetes Care (TNDM), InMode (INMD), Liquidia (LQDA), Kestra Medical Technologies (KMTS), BioLife Solutions (BLFS), MiMedx Group (MDXG), Establishment Labs (ESTA), Paragon 28 (FNA), and RxSight (RXST). These companies are all part of the "medical equipment" industry.
Semler Scientific vs.
Cadre (NYSE:CDRE) and Semler Scientific (NASDAQ:SMLR) are both small-cap industrials companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, media sentiment, profitability, community ranking, institutional ownership, earnings, valuation and dividends.
Cadre presently has a consensus price target of $37.00, indicating a potential upside of 18.32%. Semler Scientific has a consensus price target of $71.00, indicating a potential upside of 67.53%. Given Semler Scientific's higher probable upside, analysts clearly believe Semler Scientific is more favorable than Cadre.
44.0% of Cadre shares are held by institutional investors. Comparatively, 49.4% of Semler Scientific shares are held by institutional investors. 37.0% of Cadre shares are held by company insiders. Comparatively, 30.2% of Semler Scientific shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Cadre has a beta of 1.3, indicating that its share price is 30% more volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 1.33, indicating that its share price is 33% more volatile than the S&P 500.
Cadre has higher revenue and earnings than Semler Scientific. Semler Scientific is trading at a lower price-to-earnings ratio than Cadre, indicating that it is currently the more affordable of the two stocks.
Cadre received 14 more outperform votes than Semler Scientific when rated by MarketBeat users. However, 66.67% of users gave Semler Scientific an outperform vote while only 55.17% of users gave Cadre an outperform vote.
Semler Scientific has a net margin of 72.65% compared to Cadre's net margin of 6.34%. Semler Scientific's return on equity of 50.77% beat Cadre's return on equity.
In the previous week, Cadre had 7 more articles in the media than Semler Scientific. MarketBeat recorded 11 mentions for Cadre and 4 mentions for Semler Scientific. Semler Scientific's average media sentiment score of 0.88 beat Cadre's score of 0.66 indicating that Semler Scientific is being referred to more favorably in the news media.
Summary
Semler Scientific beats Cadre on 10 of the 16 factors compared between the two stocks.
Get Semler Scientific News Delivered to You Automatically
Sign up to receive the latest news and ratings for SMLR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Semler Scientific Competitors List
Related Companies and Tools
This page (NASDAQ:SMLR) was last updated on 3/25/2025 by MarketBeat.com Staff
